Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 701–800 of 1,000
Unveiling the metabolomic profile of growth hormone deficiency children using NMR spectroscopy
Aggelaki, E. A., Giannakopoulos, A., Georgiopoulou, P. D., Chasapi, S. A., Efthymiadou, A., Kritikou, D., Chrysis, D., & Spyroulias, G. A. (2025) · Metabolomics · doi:10.1007/s11306-024-02217-9 · Cited by 4
“Thus, based on our results we could only highlight a reduction in FAs in children with GHD, while GH treatment tented to normalize FAs levels, in accordance with the well-established lipolytic effect of GH (Molitch et al., 2011).”
Jensterle, M., Herman, R., Klinc, A., Goričar, K., Rakuša, M., & Janež, A. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.03.005 · Cited by 6
Kann, P. H., Bergmann, S. R., Stalla, G. K., Dimopoulou, C., Weber, M. M., Pedersen, B. T., & Meckes-Ferber, S. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1296130 · Cited by 4
Yovich, J. L., Zaidi, S. N. S. J. H., Nguyen, M. D., & Hinchliffe, P. M. (2020) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2020.13.3.0355 · Cited by 4
Freda, P. U. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101824 · Cited by 4
Choukair, D., Mittnacht, J., Treiber, D., Hoffmann, G. F., Grasemann, C., Huebner, A., Berner, R., Burgard, P. J., Szendroedi, J., & Bettendorf, M. (2024) · Clinical Endocrinology · doi:10.1111/cen.15105 · Cited by 4
“6,7 Further, patients with chronic endocrine disorders may have impaired fertility, which should be already assessed by a paediatric endocrinologist, and if present should lead to referral to an adult fertility specialist.”
Yuen, K. C. J., Frystyk, J., Rhoads, S. A., & Bidlingmaier, M. (2015) · Pituitary · doi:10.1007/s11102-015-0688-8 · Cited by 4
HIROHATA, T., Saito, N., Takano, K., Yamada, S., Son, J.-H., Yamada, S. M., Nakaguchi, H., Hoya, K., Murakami, M., Mizutani, A., et al. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0196 · Cited by 4
Impacto presupuestario de la utilización de hormona de crecimiento de la edad pediátrica a la adulta
Sanz, M. A. D., Díaz‐Cerezo, S., Oyagüez, I., & Gómez, M. Á. C. (2011) · Farmacia Hospitalaria · doi:10.1016/j.farma.2010.11.004 · Cited by 4
Review of growth hormone therapy in adolescents and young adults with Prader–Willi syndrome
Lucas-Herald, A. K., Perry, C. G., & Shaikh, M. G. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1007126 · Cited by 4
Dullaart, R. P. F., van den Berg, G., van der Knaap, A. M., Dijck-Brouwer, J., Dallinga‐Thie, G. M., Zelissen, P. M. J., Sluiter, W. J., & van Beek, A. P. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0742 · Cited by 5
Varewijck, A. J., Lamberts, S. W. J., van der Lely, A. J., Neggers, S. J. C. M. M., Hofland, L. J., & Janssen, J. A. M. J. L. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0048 · Cited by 4
Pituitary Dysfunction in Systemic Disorders
Fleseriu, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00011-8 · Cited by 4
Primary and Secondary Hypogonadism
Santi, D., & Corona, G. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_24-1 · Cited by 4
Hematuria as an adverse outcome following provocative growth hormone stimulation testing in children
Thirunagari, R., Marrone, A., Elsinghorst, H., & Mastrandrea, L. D. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0458 · Cited by 4
Metabolic Profile and Echocardiographic Evaluation in Adults with Growth Hormone Deficiency
Yang, H., Xu, H., Wang, L., Duan, L., Gong, F., Zhu, H., & Pan, H. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1941-8556 · Cited by 4
Growth hormone deficiency in adult survivors of childhood brain tumors treated with radiation
Baunsgaard, M. M., Helligsoe, A. S. L., Henriksen, L. T., Mikkelsen, T. S., Callesen, M. T., Weber, B., Hasle, H., & Birkebæk, N. (2022) · Endocrine Connections · doi:10.1530/ec-22-0365 · Cited by 6
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Hypertension in growth hormone excess and deficiency
Mihai, G., & Korbonits, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00017-0 · Cited by 5
Balwi, R. A., Al-Qahtani, M. H., Alrowished, A. K., Shash, H. A., Al-Atrash, R. S., Alhareth, A. S. A., Aldossary, R., Alahmari, M., Hejazi, Y., AlAmmari, A. M., et al. (2023) · Children · doi:10.3390/children10081381 · Cited by 4
“Furthermore, we found it reasonable to assess the agreement of the CST in relation to the ITT because the ITT has been traditionally accepted as the gold standard test for assessing adult GHD [25] because of its sensitivity and reproducibility [26], and because it enables the simultaneous assessment of the entire hypo…”
Diagnosing and treating the elderly individual with hypopituitarism
Corsello, A., Paragliola, R. M., & Salvatori, R. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09870-w · Cited by 5
“In this setting an age-adjusted low serum IGF-1, is sufficient to diagnose GHD [26, 124].”
InfluentialBayram, F., Başkol, G., Tanrıverdi, F., Başkol, M., Koçer, D., & Caniklioğlu, A. (2013) · Europe PMC (PubMed Central) · Cited by 4
Diseases of Hypothalamic Origin
Carmichael, J. D., & Braunstein, G. D. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00096-6 · Cited by 3
Ren, S., Nie, Y., & Wang, A. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3831 · Cited by 5
Markkanen, H. M., Pekkarinen, T., Hämäläinen, E. K., Välimäki, M. J., Alfthan, H. V., & Stenman, U. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.07.002 · Cited by 4
Züger, T., Loher, H., Egger, A., Boesch, C., & Christ, E. (2016) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2016.03.007 · Cited by 5
“2 ng/ml for BMI b25, 25–30 and N30 kg/m respectively), or insufficiency of at least three pituitary axes in addition to a low value for insulin-like growth factor 1 (IGF-1) [5,21,22].”
BackgroundGunn, M. E., Lähdesmäki, T., Malila, N. K., Arola, M. O., Grönroos, M. H., Matomäki, J., & Lähteenmäki, P. M. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2134-9 · Cited by 5
Discovery and uses of pegvisomant: a growth hormone antagonist.
Berryman, D. E., Palmer, A. J., Sustarsic, E. G., Swaminathan, S., DeSantis, D., & Kopchick, J. J. (2007) · PubMed · Cited by 5
Endocrine Complications of Cancer Therapy
Rose, S. R., Lawson, S. A., Burns, K. C., & Merchant, T. E. (2015) · Pediatric oncology · doi:10.1007/978-3-319-16435-9_5 · Cited by 4
Garcia, J. M., Merriam, G. R., & Kargi, A. Y. (2015) · Cited by 5
Self-citationLipworth, W. L., Ambler, G. R., Burt, M. G., Fairchild, J. M., Inder, W. J., Werther, G. A., & Ho, K. K. Y. (2018) · Internal Medicine Journal · doi:10.1111/imj.13943 · Cited by 4
“This, in turn, has an impact upon working capacity, life satisfaction, and productivity.(1) 5-7”
BackgroundAlmalki, M., Ekhzaimy, A. A., Beshyah, S., & Dahmani, K. A. (2020) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_46_20 · Cited by 5
Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver Disease
Pοlyzos, S. A., Mantovani, A., & Targher, G. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00692-w · Cited by 4
Seki, Y., & Ichihara, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267324 · Cited by 4
Gasco, V., Matarazzo, P., SANCTIS, L. D., & Ghigo, E. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-251897 · Cited by 3
Effect of growth hormone to spinal growth and recombinant human growth hormone to scoliosis
Luo, C., Liu, S., Li, Y., Wu, Q., Liu, Q., Peng, D., Shu, H., Xu, X., & Wen, J. (2024) · Translational Pediatrics · doi:10.21037/tp-24-180 · Cited by 7
Detomas, M., Deutschbein, T., Dolce, P., Möhres, Y., Faßnacht, M., & Altieri, B. (2025) · Pituitary · doi:10.1007/s11102-024-01493-x · Cited by 3
Neuroendocrine changes during the acute phase following traumatic brain injury
Lonergan, E. M., & Agha, A. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102003 · Cited by 4
Oikonomakos, I. T., Siow, R. C. M., Bornstein, S. R., & Steenblock, C. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2641-1207 · Cited by 5
Effects of short term growth hormone therapy in adult growth hormone deficiency.
Dutta, P. R., Bhansali, A. K., Kumar, B. V. A., Sharma, R., Jaggi, S., & Bhadada, S. K. (2010) · PubMed · Cited by 3
Giavoli, C., Profka, E., Sala, E., Filopanti, M., Barbieri, A. M., Bergamaschi, S., Ferrante, E., Arosio, M., Ambrosi, B., Lania, A. G., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0600 · Cited by 3
Early versus late initiation of GH replacement in adult-onset hypopituitarism
Postma, M. R., Burman, P., & van Beek, A. P. (2020) · Endocrine Connections · doi:10.1530/ec-20-0098 · Cited by 4
When They're Done Growing, Don't Forget They May Still Need Growth Hormone
Henry, R. K. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0130 · Cited by 3
Corrales, E. P., Castro, M. A., Ortiz-Flores, A. E., & Escobar-Morreale, H. F. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.09.004 · Cited by 3
Roy, A., Suryadevara, V., Nagarajan, K., Sahoo, J., Naik, D., Perumal, N. L., Narayanan, N., Merugu, C., Patel, D., Patil, M., et al. (2022) · Neurology India · doi:10.4103/0028-3886.359201 · Cited by 3
Schnabel, D., Kreitschmann‐Andermahr, I., Strasburger, C. J., Pittrow, D., Pausch, C., Woelfle, J., & for the INSIGHTS-GHT Study Group (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02716-3 · Cited by 4
“Adult GHD can persist from childhood, or occurs due to structural lesions such as pituitary adenomas and other tumours of the sellar region, radiotherapy to the pituitary, traumatic brain injury and other rare causes [3].”
BackgroundCarter‐Su, C., Argetsinger, L. S., & Svezhova, N. V. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00265.2023 · Cited by 5
Kargi, A. Y. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101825 · Cited by 7
Zhang, D., & Gu, M. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01137-y · Cited by 5
“However, children who do not receive head irradiation usually reach a normal height in adulthood [10].”
BackgroundDutta, D., Nagendra, L., Mohindra, R., Bhattacharya, S., Joshi, A. S., & Kamrul-Hasan, A. B. M. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_488_23 · Cited by 3
Spexin level in growth hormone deficiency Iraqi children
Ghannawi, L. A., Gharab, K. M. K., Hadi, M. A., Shakir, O. Y., & Rahmah, A. M. (2024) · The Ukrainian Biochemical Journal · doi:10.15407/ubj96.04.055 · Cited by 3
Nakamura, A., Miyado, K., Yamatoya, K., Kawano, N., & Umezawa, A. (2015) · Regenerative Therapy · doi:10.1016/j.reth.2015.11.001 · Cited by 3
Growth Hormone and ACTH Deficiency in a Diabetic Adult
Memon, A., Gilani, M., Asif, N., & Basharat, N. (2019) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2019.06.s2 · Cited by 3
Golounina, O. O., Pavlova, M. G., Belaya, Z. E., Kim, E. I., Glinkina, I. V., Моргунова, Т. Б., Mazerkina, N. A., Zheludkova, O., & Fadeev, V. V. (2021) · Problems of Endocrinology · doi:10.14341/probl12680 · Cited by 3
Portes, E., & Barbosa, E. R. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500018 · Cited by 10
Álvarez‐Escolá, C., Fernández-Rodríguez, E., Recio‐Córdova, J. M., Bernabéu, I., & Fajardo, C. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.08.001 · Cited by 5
Yuen, K. C. J., & POPOVIC, V. M. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.996130 · Cited by 3
Micmacher, E., Conceição, F. L., Netto, L. S., Redorat, R. G., Biesek, S., Gold, J., Cenci, M. C. P., Santos, M. J. C. F., Taboada, G. F., Assumpção, R. P., et al. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.07.010 · Cited by 3
Exercise-induced GH secretion in the assessment of GH deficiency in adult individuals
Züger, T., Alleman, S., Christ, E., & Stettler, C. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0539 · Cited by 3
Disfunción neuroendocrina y lesión cerebral traumática
Leal‐Cerro, A., Rincón, M. D., & Puig‐Domingo, M. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.07.020 · Cited by 3
Single and Combined Effects of Growth Hormone and Testosterone in Healthy Older Men
WELTMAN, A. L., & Veldhuis, J. D. (2006) · Hormone Research in Paediatrics · doi:10.1159/000096623 · Cited by 3
Deficiência de GH na vida adulta: como diagnosticar e quando tratar?
Jallad, R. S., & Bronstein, M. D. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500019 · Cited by 6
LABORATORIO DE HORMONAS: ASPECTOS PRÁCTICOS
René Díaz, T., Jesús Véliz, L., & Nelson Wohllk, G. (2015) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2015.11.006 · Cited by 4
Normal reference range of serum insulin-like growth factor (IGF)-I in healthy Thai adults.
Plengpanich, W., Mangkala, J., Buranasukajorn, P., Boonruang, K., Sunthornyothin, S., Suwanwalaikorn, S., Khovidhunkit, W., Sridama, V., & Snabboon, T. (2008) · PubMed · Cited by 3
Growth Hormone Stimulation Tests in Assessing Adult Growth Hormone Deficiency
Yuen, K. C. J. (2016) · Europe PMC (PubMed Central) · Cited by 9
Management of Adults with Childhood-Onset Growth Hormone Deficiency
Prete, A., & Salvatori, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_7 · Cited by 3
Leonhardt, M., Kopczak, A., Schäpers, B., Limbrock, J., Sämann, P. G., Czisch, M., von Steinbüchel, N., Jordan, M., Schneider, H. J., Schneider, M., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00723 · Cited by 4
Borson‐Chazot, F., Chabre, O., Salenave, S., Klein, M., de la Perrière, A. B., Reznik, Y., Kerlan, V., Hacques, E., & Villette, B. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.11.007 · Cited by 4
Reduced Bone Mineral Density in Middle-Aged Male Patients with Adult Growth Hormone Deficiency
Liu, S., Yang, H., Xu, H., Zhou, Z., Bai, X., Wang, L., Duan, L., Gong, F., Zhu, H., & Pan, H. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1850-7461 · Cited by 4
The Endocrine Society Clinical Practice Guidelines: A Self-Assessment
Vigersky, R. A., Bhasin, S., & Martin, K. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2300 · Cited by 3
Chen, S. C., Lucas-Herald, A. K., Tang, R., Tseretopoulou, X., Alimussina, M., Andrews, D., Biller, B. M. K., Boguszewski, C. L., Bryce, J., Chen, M., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.15298 · Cited by 3
Fei, S., Yang, A., Jin, Y., Tian, L., Yu, X., Liang, S., Zhang, W., Zhao, G., & Gao, B. (2025) · Postgraduate Medicine · doi:10.1080/00325481.2025.2570106 · Cited by 2
“In contrast, low-dose rhGH (0.1–0.5 mg/day) has been recommended for replacement therapy in adult GH deficiency, with dose adjustments based on clinical response, adverse effects, and serum insulin-like growth factor-1 (IGF-1) levels [17].”
InfluentialGrowth hormone treatment in adults with Prader-Willi syndrome: an update
Grugni, G., & Sartório, A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2571215 · Cited by 2
“In the general population, elderly patients have a greater susceptibility to GH-related side effects [120].”
Growth Hormone, Not Simply Just a Hormone for Growth
Yuen, K. C. J., Guevara‐Aguirre, J., & Kopchick, J. J. (2026) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2806 · Cited by 2
Milioto, A., Espósito, D., Johannsson, G., & Ragnarsson, Ó. (2026) · Pituitary · doi:10.1007/s11102-026-01646-0 · Cited by 3
Mishra, V., Martinez, M., & Weppner, J. L. (2026) · Journal of Neurotrauma · doi:10.1177/08977151261434917 · Cited by 2
Fleseriu, M., Biller, B. M. K., Webb, S. M., Strasburger, C. J., Georgescu, C. E., Bidlingmaier, M., Wang, C., Baciu, I. F., Casanueva, F. F., Gilis‐Januszewska, A., et al. (2026) · Pituitary · doi:10.1007/s11102-026-01661-1 · Cited by 3
DISORDERS OF THE HYPOTHALAMIC-PITUITARY AXIS
Yu, R., & Braunstein, G. D. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50044-5 · Cited by 2
Vergani, E., Bruno, C., Napodano, C., Gulli, F., Stefanile, A., Piunno, G., Basile, U., & Mancini, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110757 · Cited by 2
Höybye, C., Beck‐Peccoz, P., Murray, R. D., Şimşek, S., Stalla, G. K., Strasburger, C. J., Urosevic, D., Zouater, H., & Johannsson, G. (2021) · Pituitary · doi:10.1007/s11102-021-01139-2 · Cited by 3
Gogna, R., Jung, C., McLachlan, K., Krishnamurthy, B., Hong, A., Derbyshire, M. M., Kiburg, K., Zacharin, M., MacIsaac, R. J., Sachithanandan, N., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14464 · Cited by 3
Adherence and quality of life in children receiving rhGH treatment
González-Briceño, L., Viaud, M., & Polak, M. (2022) · Archives de Pédiatrie · doi:10.1016/s0929-693x(22)00036-7 · Cited by 2
Pituitary dysfunction after traumatic brain injury: A focus on screening, diagnosis, and treatment
Hacıoğlu, A., Karaca, Z., & Keleştimur, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00026-9 · Cited by 3
Herman-Bonert, V. S., & Melmed, S. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00023-8 · Cited by 7
Gadelha, M. R., Wildemberg, L. E., & Kasuki, L. (2022) · The Pituitary · doi:10.1016/b978-0-323-99899-4.00003-2 · Cited by 2
Khan, M. Q., Hassan, S. M., Lizaola‐Mayo, B., Bhat, M., & Watt, K. D. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000674 · Cited by 3
Costanzo, G., Naselli, A., Arpi, M. L., Piticchio, T., Moli, R. L., Belfiore, A., & Frasca, F. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02270-6 · Cited by 3
“Growth hormone deficiency (GHD) was defined as serum GH peak below 9 µg/l after GHRH + arginine stimulation test [22] (performed 1 µg/kg with GHRH, Ferring Pharmaceuticals Ltd., Hoofddorp, The Netherlands, up to 100 µg, and 0.5 g/kg arginine chlorhydrate, up to 30 g).”
InfluentialGH provocative tests stimulate the growth in children with idiopathic short stature
Tortora, A., Marotta, V., Izzo, G., Rocco, D., Clemente, G., & Vitale, M. (2024) · Endocrine · doi:10.1007/s12020-024-03860-x · Cited by 2
Caputo, M., Pigni, S., Mele, C., Pitino, R., Marzullo, P., Prodam, F., & Aimaretti, G. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09938-1 · Cited by 2
Klinc, A., Janež, A., & Jensterle, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052010 · Cited by 2
“The target is commonly set in the upper-normal range [10], as emerging evidence suggests high-normal IGF-1 SDSs (1 to 2 SD) may be associated with a more favorable body composition and wellbeing [12,13].”
InfluentialGilis‐Januszewska, A., Kluczyński, Ł., Wilusz, M., Pantofliński, J., Turek-Jabrocka, R., Pach, D., & Hubalewska–Dydejczyk, A. (2017) · Medicine · doi:10.1097/md.0000000000008406 · Cited by 2
Use of the Growth Hormone Stimulation Test Result in the Management of Patients With a Short Stature
Mahzari, M. M., Al-Joufi, F. A., Otaibi, S. A., Hassan, E., & Masuadi, E. (2020) · Cureus · doi:10.7759/cureus.10988 · Cited by 2
Choi, J., & Yoo, H. (2011) · Journal of Korean Society of Pediatric Endocrinology · doi:10.6065/jkspe.2011.16.1.1 · Cited by 2
Postradiation therapy hypopituitarism
Hatipoğlu, B., & Kennedy, L. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.82 · Cited by 2
Traitement par l'hormone de croissance des adultes présentant un déficit en hormone de croissance
Chanson, P., & Salenave, S. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.013 · Cited by 3
Hasan, H., Howard, A. F., Morgan, S. G., Metzger, D. L., Lo, A., Goddard, K., Gill, S., & Johnson, M. S. (2014) · Healthcare policy · doi:10.12927/hcpol.2014.23728 · Cited by 3
Acromegaly as a Complication of Growth Hormone Therapy
Eskander, E. T., & Bonert, V. S. (2015) · AACE Clinical Case Reports · doi:10.4158/ep14165.cr · Cited by 2
Yamagata, S., Kageyama, K., Murasawa, S., Tomotsune, K., Kawashima, S., Makita, K., Yamamoto, Y., Shimaya, K., Numao, H., Tazawa, Y., et al. (2015) · AACE Clinical Case Reports · doi:10.4158/ep15763.cr · Cited by 2
Hematopoietic Stem Cell Transplant
Nathan, P. C., Gassas, A., & Wasserman, J. D. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7584-3_13 · Cited by 2
Peak oxygen uptake test in the assessment of growth hormone deficiency
Züger, T., Bucher, J., Christ, E., & Stettler, C. (2014) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2013-0483 · Cited by 2
“2 ng/mL for BMI <25, 25–30, and >30 kg/m2, respectively), or insufficiency of at least 3 pituitary axes in addition to a low value for insulin-like growth factor-1 (Corneli et al. 2005; Molitch et al. 2006; Molitch et al. 2011).”
Background
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.